BOSTON, November 1, 2023: Morgan Lewis advised enGene Holdings Inc., a clinical-stage genetic medicines company, on the completion of its business combination with Forbion European Acquisition Corp., a special purpose acquisition company (SPAC).
enGene is a clinical-stage biotechnology company advancing genetic medicine by delivering therapeutics to mucosal tissues and other organs, aiming to develop innovative treatments for diseases with significant unmet clinical needs.
Partners Julio Vega, Todd Hentges, and Howard Kenny and associate Tara McElhiney advised enGene, with of counsel Thurston Hamlette; associates Maria Sasinoski, Kelsey Warren, Lixin Ayrik, and Alexia Jaber; and partners Patrick Rehfield, Sula Fiszman, and Richard Zarin.